Pages that link to "Q51019935"

The following pages link to Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury (Q51019935):

Displaying 43 items.

• The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease (Q28068647) (← links)
• Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo (Q33316622) (← links)
• The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation (Q33685912) (← links)
• Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation (Q33830064) (← links)
• Partial Netrin-1 Deficiency Aggravates Acute Kidney Injury (Q33916670) (← links)
• Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats. (Q34020021) (← links)
• Cellular function and molecular structure of ecto-nucleotidases. (Q34031794) (← links)
• Ticlopidine in its prodrug form is a selective inhibitor of human NTPDase1 (Q34087391) (← links)
• Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states (Q34703746) (← links)
• The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance (Q34769236) (← links)
• Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury. (Q35085768) (← links)
• CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection (Q35202450) (← links)
• Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia (Q35574518) (← links)
• Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury. (Q35632965) (← links)
• Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli (Q36174033) (← links)
• Cell-surface enzymes in control of leukocyte trafficking (Q36274918) (← links)
• Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation (Q36350059) (← links)
• Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine (Q36516823) (← links)
• Intestinal ischemia-reperfusion injury alters purinergic receptor expression in clinically relevant extraintestinal organs (Q36571085) (← links)
• Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding? (Q36779378) (← links)
• Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury (Q36804999) (← links)
• NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. (Q36961254) (← links)
• Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury (Q36999844) (← links)
• Central role of Sp1-regulated CD39 in hypoxia/ischemia protection (Q37039131) (← links)
• The calcium activated nucleotidases: A diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes (Q37135540) (← links)
• Biological implications of extracellular adenosine in hepatic ischemia and reperfusion injury (Q37248599) (← links)
• Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice. (Q37297986) (← links)
• Hypoxia signaling during intestinal ischemia and inflammation (Q37373524) (← links)
• The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury (Q38063159) (← links)
• 8-BuS-ATP derivatives as specific NTPDase1 inhibitors. (Q39989919) (← links)
• The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active (Q40121574) (← links)
• Ectonucleotidase CD39-driven control of postinfarction myocardial repair and rupture (Q40766858) (← links)
• Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation. (Q41149629) (← links)
• Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury (Q42199760) (← links)
• Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk (Q43102079) (← links)
• Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. (Q43140401) (← links)
• Protective effects of leflunomide on intestinal ischemia-reperfusion injury: leflunomide against intestinal ischemia-reperfusion (Q46116237) (← links)
• Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells (Q46151387) (← links)
• Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. (Q46175545) (← links)
• Protective effects of caffeic acid phenethyl ester on intestinal ischemia-reperfusion injury (Q46443684) (← links)
• Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertension. (Q47298425) (← links)
• CD39-adenosinergic axis in renal pathophysiology and therapeutics (Q47655859) (← links)
• The role of platelets in acute kidney injury (Q88671029) (← links)